Beyond Air Stock (NASDAQ:XAIR), Trade Ideas

Beyond Air

Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

News

Penny Stocks

Health Care

Movers

General

XAIR

Beyond Cancer Ltd, an affiliate of Beyond Air Inc (NASDAQ: XAIR), announced that the Phase 1 Study evaluating ultra-high concentration nitric oxide (UNO) in advanced, relapsed or refractory unresectable, primary or metastatic cutaneous and subcutaneous solid tumors has cleared the

Medical Device Player Beyond Air&#39;s Subsidiary Reveals Encouraging Data From Early-Stage Cancer Study

Small Cap

Intraday Update

Markets

Trading Ideas

ACON

AGRI

ARGX

ASST

AUVI

BLUE

CRGX

DESP

FLNC

GMBL

HCDI

HIVE

IMVT

KULR

LQDA

MGNX

MNKD

Nuveen Insured California Premium Fund Ii

NOGN

PBLA

PRZO

RDHL

TTOO

VSTE

ZJYL

Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday&#39;s session following quarterly results.

Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Long Ideas

Insider Trades

Pre-Market Outlook

BCAB

CRDF

CYAN

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Beyond Air Inc

WIIM

PXMD

PaxMedica shares are trading higher after the company received an emergency request form the Ministry of Health of Malawi, asking for emergency access to IV suramin.

Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.25) by 4 percent. This is a 25 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $2.29 million which missed the analyst consensus estimate of $2.46 million by 7.03 percent. This is a 43.75 percent decrease over sales of $4.07 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

XELB

Xcel Brands Q4 EPS $(0.24) Beats $(0.25) Estimate, Sales $2.29M Miss $2.46M Estimate

ADSK

Autodesk shares are trading lower after the company announced that it will not file its Annual Report on Form 10-K for the year ended January 31, 2024 within the 15-day extension period. The company provided an update on the previously reported internal investigation that is currently being conducted by the Audit Committee.

<ul>
<li>Emergent shortages of the drug used to treat the most severe form of African sleeping sickness creates immediate need for direct access to the global drug market for affected nations</li>
<li>As previously <a href="https://www.paxmedica.com/press-releases/paxmedica-achieves-key-milestone-in-the-development-of-pax-101-and-provides-update-on-potential-nda-submission">reported</a>, PaxMedica recently executed final registration and validation batches of PAX-101 (an IV form of suramin) in preparation for a future NDA submission as an orphan designated drug</li>
</ul>
TARRYTOWN, New York, April 16, 2024 (GLOBE NEWSWIRE) -- via IBN --&nbsp;<a href="https://www.globenewswire.com/Tracker?data=CLx5G81-BiPJx8zWyrDsXviAROm2hWjM23ga69sZUo66V7Dv6F0FD3tm9nyySM7R5AVgRk0-_Pi9_mMWbLUdDQ==">PaxMedica</a>, Inc. (NASDAQ:&nbsp;<a href="https://www.globenewswire.com/Tracker?data=FNQeGJNeLvOrTYV1Tb4I4EQg2Mnh25XCi6Q3cL16-NnDhf-vO0voR9s6Dq2qw_VRzYM4hpa8Etz6CUQtZHllQw-x-sGIcFj5v5U3AUcn_BfRr34P198T7co4bDup3ewW">PXMD</a>), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced it has received an urgent request from the Ministry of Health (MOH) of Malawi, asking for emergency access to IV suramin to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used routinely to save lives in that region of Africa.
PaxMedica, which just last week announced that it has completed execution of its three pivotal registration/validation batches of PAX-101 (an IV form of suramin), has brought this emergency request to the attention of the U.S. Food and Drug Administration (FDA) to determine potential impact, if any, on the ongoing development program and NDA submission plans for PAX-101. PaxMedica has previously announced the completion of its recent Type B meeting with FDA in preparation for submitting an NDA for the use of PAX-101 in the treatment of the rare and fatal trypanosomal infection, Trypanosoma brucei rhodesiense, caused by the bite of a tsetse fly.
"Receiving this request from The Ministry of Health of Malawi serves to emphasize, not only the challenging situation faced by the countries in the most vulnerable zone for the fatal disease, TBr HAT, it speaks to the continued need for suramin as the standard of care in treating Stage 1 of the infection, using what's known as the Malawi dosing protocol, which they have used in an effort to save lives in that region for nearly 100 years", said Howard Weisman, Chairman and CEO of PaxMedica. "FDA has agreed that having more than one global manufacturer of drugs like suramin could provide public health benefit by creating multiple supply chains and would help ensure a steady supply of the drug product."
It is important to note that, of the 349 patients who were included in our Real World retrospective evidence, HAT-301 clinical study of TBR HAT patients treated with suramin between 2000 and 2020, many of the cases were from Malawi. (<a href="https://www.globenewswire.com/Tracker?data=CLx5G81-BiPJx8zWyrDsXrXq2d6AbS3ML9pImzpDsVdyOjeVuaJ3V1aZ6Ak94jKXdx_p5Z5kiZ5m_6yn2Fzid4CYenttr_SS3_WD9sOC_YgZFXZTM2ci-YZ3BeGj3iGWWhJFG0ZFmTwAjoPSN0-uk2IroHtwIlX5LQE9tQ5ZiUpJVPEui3WYUZiXjRTIIdJQdLwRf7ZhLxXbTNNOsPr2EZ05TSJUYLIQUzuTJvR6CfxmId1EPR8wTsllh8PVxMNcfc6c7ty5ZKwaDRRlhZYNJWB4VOe1prN6qalUvEX2KaB05Ww6q297vrDRwpSBX90B">PaxMedica - A Promising Path in Autism</a>) "Having the highest incidence of TBr HAT in the world, the Malawi Ministry of Health enabled PaxMedica to conduct the first and only analysis of efficacy in the actual setting where historically the vast majority of these infections have been successfully treated", said Weisman. "This pivotal Phase 3 study would not have been possible without their multi-year commitment to our work on PAX-101."
PaxMedica is in the process of responding to the Malawi Ministry of Health's request and is in contact with regulatory authorities in both the U.S. and Malawi with an intention to help with today's emergency, as well as to work with the FDA to determine the best path forward to submit the PAX-101 NDA for regulatory approval, as well as to potentially qualify for a Priority Review Voucher under the Neglected Tropical Disease Priority Review Voucher Program, which could provide PaxMedica resources to help ensure a steady supply of suramin to these endemic regions."

Biotech

Global

PaxMedica Receives Emergency Request For IV Suramin From African Health Ministry For Use In Treating Fatal Sleeping Sickness

Fulton Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) reported quarterly Adj earnings of $0.40 per share which beat the analyst consensus estimate of $0.39 by 2.56 percent. This is a 2.56 percent increase over earnings of $0.39 per share from the same period last year.

FULT

Fulton Financial Q1 Adj EPS $0.40 Beats $0.39 Estimate

<h3>Gainers</h3>
<ul>
<li>2U (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) shares moved upwards by 8.3% to $0.32 during Tuesday's after-market session. The market value of their outstanding shares is at $26.7 million. </li>
<li>Newegg Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) shares moved upwards by 4.75% to $0.76. The company's market cap stands at $288.7 million. </li>
<li>Linkage Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCB#NASDAQ">LGCB</a>) stock rose 4.19% to $3.23. The market value of their outstanding shares is at $69.4 million. </li>
<li>Vision Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) shares rose 4.05% to $0.6. The company's market cap stands at $7.0 million. As per the press release, Q2 earnings came out yesterday. </li>
<li>Tupperware Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUP#NYSE">TUP</a>) shares rose 3.82% to $1.0. The company's market cap stands at $46.5 million. </li>
<li>ToughBuilt Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLT#NASDAQ">TBLT</a>) shares rose 2.73% to $2.25. The company's market cap stands at $1.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) stock decreased by 4.8% to $1.0 during Tuesday's after-market session. The market value of their outstanding shares is at $257.5 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) stock decreased by 4.64% to $0.23. The market value of their outstanding shares is at $5.0 million. </li>
<li>Golden Sun Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) shares fell 3.85% to $0.5. The company's market cap stands at $9.5 million. </li>
<li>Charles &amp; Colvard (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTHR#NASDAQ">CTHR</a>) stock decreased by 3.08% to $0.33. The market value of their outstanding shares is at $9.9 million. </li>
<li>Allbirds (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIRD#NASDAQ">BIRD</a>) shares decreased by 2.8% to $0.59. The company's market cap stands at $92.1 million. </li>
<li>Selina Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) stock decreased by 2.37% to $0.06. The market value of their outstanding shares is at $18.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIRD

CTHR

GSUN

LGCB

NAAS

NEGG

SLNA

TBLT

TWOU

VMAR

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) shares moved upwards by 54.9% to $0.48 during Tuesday's after-market session. The company's market cap stands at $61.6 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) shares moved upwards by 11.65% to $1.15. The company's market cap stands at $19.5 million. </li>
<li>Lexaria Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) stock moved upwards by 8.22% to $2.5. The market value of their outstanding shares is at $32.2 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock increased by 7.14% to $1.8. The market value of their outstanding shares is at $2.3 million. </li>
<li>IGC Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IGC#AMEX">IGC</a>) shares rose 6.99% to $0.52. The company's market cap stands at $34.3 million. </li>
<li>SHL Telemedicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLT#NASDAQ">SHLT</a>) stock increased by 6.94% to $5.39. The market value of their outstanding shares is at $88.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares fell 15.9% to $0.31 during Tuesday's after-market session. The company's market cap stands at $9.2 million. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock decreased by 14.53% to $0.47. The market value of their outstanding shares is at $2.2 million. </li>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) stock decreased by 13.29% to $0.4. The market value of their outstanding shares is at $16.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock fell 12.35% to $1.42. </li>
<li>PaxMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXMD#NASDAQ">PXMD</a>) shares fell 9.75% to $0.6. The market value of their outstanding shares is at $4.4 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) stock declined by 9.35% to $3.2. The company's market cap stands at $10.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLNN

CYCC

DYNT

LEXX

LGVN

OTRK

SHLT

SXTC

TBIO

TLPH

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Ideanomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDEX#NASDAQ">IDEX</a>) shares moved upwards by 5.0% to $0.84 during Tuesday's after-market session. The company's market cap stands at $10.0 million. </li>
<li>Sentage Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTG#NASDAQ">SNTG</a>) shares rose 4.81% to $1.96. The company's market cap stands at $5.4 million. </li>
<li>United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) shares moved upwards by 4.74% to $43.49. The company's market cap stands at $14.2 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Mesa Air Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESA#NASDAQ">MESA</a>) stock moved upwards by 2.63% to $0.82. The company's market cap stands at $33.6 million. </li>
<li>Smart Powerr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREG#NASDAQ">CREG</a>) stock rose 2.56% to $1.2. The market value of their outstanding shares is at $9.5 million. As per the press release, Q4 earnings came out 3 days ago. </li>
<li>Desktop Metal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DM#NYSE">DM</a>) shares moved upwards by 2.36% to $0.87. The market value of their outstanding shares is at $287.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Dragonfly Energy Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) stock fell 12.8% to $0.54 during Tuesday's after-market session. The company's market cap stands at $31.8 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) shares declined by 7.75% to $1.77. The company's market cap stands at $24.0 million. </li>
<li>JB Hunt Transport Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) shares fell 5.74% to $172.5. The company's market cap stands at $17.8 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) stock declined by 4.59% to $0.25. The company's market cap stands at $12.2 million. </li>
<li>Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) shares declined by 4.22% to $0.47. The market value of their outstanding shares is at $48.4 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares fell 3.88% to $1.24. The market value of their outstanding shares is at $24.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CREG

CSLR

DFLI

GTEC

HTOO

IDEX

JBHT

KSCP

MESA

SNTG

12 Industrials Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>VIA optronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIAO#NYSE">VIAO</a>) stock rose 30.8% to $0.34 during Tuesday's after-market session. The company's market cap stands at $7.7 million. </li>
<li>CXApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXAI#NASDAQ">CXAI</a>) stock moved upwards by 8.69% to $4.25. The company's market cap stands at $64.8 million. As per the press release, Q4 earnings came out today. </li>
<li>Akoustis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) shares rose 6.9% to $0.54. The market value of their outstanding shares is at $53.2 million. </li>
<li>XIAO-I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) shares moved upwards by 6.75% to $1.58. The company's market cap stands at $113.8 million. </li>
<li>Inuvo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INUV#AMEX">INUV</a>) stock rose 5.1% to $0.34. The company's market cap stands at $47.3 million. </li>
<li>Banzai International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) shares increased by 4.98% to $0.39. The market value of their outstanding shares is at $7.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Xperi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPER#NYSE">XPER</a>) shares declined by 16.6% to $8.12 during Tuesday's after-market session. The company's market cap stands at $359.4 million. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares declined by 5.72% to $1.32. The company's market cap stands at $51.2 million. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) stock fell 4.55% to $1.47. The company's market cap stands at $3.5 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock declined by 4.45% to $2.15. The market value of their outstanding shares is at $5.1 million. </li>
<li>Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) shares declined by 4.21% to $218.64. The company's market cap stands at $46.7 billion. </li>
<li>Meta Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMAT#NASDAQ">MMAT</a>) stock fell 3.31% to $2.72. The company's market cap stands at $17.1 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIXI

AKTS

AUUD

BNZI

CXAI

GRYP

INUV

MMAT

PRSO

VIAO

XPER

12 Information Technology Stocks Moving In Tuesday's After-Market Session

Investors with a lot of money to spend have taken a bullish stance on Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with U, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 20 uncommon options trades for Unity Software.
This isn't normal.
The overall sentiment of these big-money traders is split between 75% bullish and 25%, bearish.
Out of all of the special options we uncovered, 13 are puts, for a total amount of $784,556, and 7 are calls, for a total amount of $425,714.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $50.0 for Unity Software during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Unity Software's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Unity Software's whale trades within a strike price range from $20.0 to $50.0 in the last 30 days. 
<h3>Unity Software Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713299502_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>U</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$9.9</td>
<td>$9.7</td>
<td>$9.75</td>
<td>$32.00</td>
<td>$310.0K</td>
<td>799</td>
<td style="text-align: right;">358</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$7.7</td>
<td>$7.6</td>
<td>$7.7</td>
<td>$25.00</td>
<td>$152.4K</td>
<td>52</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.95</td>
<td>$2.62</td>
<td>$2.75</td>
<td>$50.00</td>
<td>$82.5K</td>
<td>564</td>
<td style="text-align: right;">34</td>
</tr>
<tr>
<td>U</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.05</td>
<td>$5.0</td>
<td>$5.0</td>
<td>$25.00</td>
<td>$75.0K</td>
<td>1.3K</td>
<td style="text-align: right;">151</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.81</td>
<td>$2.71</td>
<td>$2.81</td>
<td>$32.00</td>
<td>$61.2K</td>
<td>1.1K</td>
<td style="text-align: right;">331</td>
</tr>
</tbody>
</table>

<h3>About Unity Software</h3>
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
After a thorough review of the options trading surrounding Unity Software, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Unity Software</h3>
<ul>
<li>With a trading volume of 6,445,468, the price of U is down by -2.21%, reaching $23.89.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 23 days from now.</li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Unity Software options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

This Is What Whales Are Betting On Unity Software

High-rolling investors have positioned themselves bullish on Lamb Weston Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in LW often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 14 options trades for Lamb Weston Hldgs. This is not a typical pattern.
The sentiment among these major traders is split, with 50% bullish and 50% bearish. Among all the options we identified, there was one put, amounting to $29,205, and 13 calls, totaling $668,030.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $65.0 to $100.0 for Lamb Weston Hldgs during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Lamb Weston Hldgs stands at 665.12, with a total volume reaching 1,510.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Lamb Weston Hldgs, situated within the strike price corridor from $65.0 to $100.0, throughout the last 30 days.
<h3>Lamb Weston Hldgs Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713299497_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.2</td>
<td>$3.9</td>
<td>$3.9</td>
<td>$100.00</td>
<td>$134.6K</td>
<td>99</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>LW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$4.3</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$92.50</td>
<td>$82.0K</td>
<td>273</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>LW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$2.4</td>
<td>$2.3</td>
<td>$2.4</td>
<td>$85.00</td>
<td>$71.7K</td>
<td>1.5K</td>
<td style="text-align: right;">11</td>
</tr>
<tr>
<td>LW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$26.0</td>
<td>$25.2</td>
<td>$25.6</td>
<td>$65.00</td>
<td>$53.7K</td>
<td>187</td>
<td style="text-align: right;">14</td>
</tr>
<tr>
<td>LW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$5.2</td>
<td>$5.0</td>
<td>$5.2</td>
<td>$77.50</td>
<td>$51.9K</td>
<td>291</td>
<td style="text-align: right;">139</td>
</tr>
</tbody>
</table>

<h3>About Lamb Weston Hldgs</h3>
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by French fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Nearly 70% of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single largest customer at 13% of fiscal 2023 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Having examined the options trading patterns of Lamb Weston Hldgs, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Lamb Weston Hldgs Standing Right Now?</h3>
<ul>
<li>With a volume of 3,104,053, the price of LW is up 2.64% at $82.06. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 98 days.</li>
</ul>
<h3>Professional Analyst Ratings for Lamb Weston Hldgs</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $107.4.
<ul>
<li>An analyst from Stifel has decided to maintain their Buy rating on Lamb Weston Hldgs, which currently sits at a price target of $115. </li>
<li>Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Lamb Weston Hldgs, targeting a price of $106. </li>
<li>Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Lamb Weston Hldgs, targeting a price of $113. </li>
<li>An analyst from Barclays has decided to maintain their Overweight rating on Lamb Weston Hldgs, which currently sits at a price target of $105. </li>
<li>An analyst from Wells Fargo has decided to maintain their Overweight rating on Lamb Weston Hldgs, which currently sits at a price target of $98. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lamb Weston Hldgs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Smart Money Is Betting Big In Lamb Weston Hldgs Options

Offerings

APi Group Announces Launch Of 11M Share Public Offering Of Common Stock

Financial giants have made a conspicuous bearish move on Baidu. Our analysis of options history for Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) revealed 18 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 10 were puts, with a value of $755,065, and 8 were calls, valued at $592,151.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $165.0 for Baidu over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Baidu's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Baidu's significant trades, within a strike price range of $75.0 to $165.0, over the past month.
<h3>Baidu Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713299491_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$29.4</td>
<td>$27.6</td>
<td>$27.6</td>
<td>$75.00</td>
<td>$317.4K</td>
<td>892</td>
<td>301</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.1</td>
<td>$8.1</td>
<td>$8.8</td>
<td>$75.00</td>
<td>$180.4K</td>
<td>46</td>
<td>5</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$45.65</td>
<td>$44.4</td>
<td>$44.9</td>
<td>$140.00</td>
<td>$179.6K</td>
<td>1</td>
<td>54</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$20.2</td>
<td>$19.75</td>
<td>$19.9</td>
<td>$105.00</td>
<td>$149.2K</td>
<td>435</td>
<td>0</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$1.11</td>
<td>$1.06</td>
<td>$1.06</td>
<td>$135.00</td>
<td>$106.0K</td>
<td>1.5K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Baidu</h3>
Baidu is the largest internet search engine in China with 84% share of the search engine market in September 2021 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2022. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
<h3>Present Market Standing of Baidu</h3>
<ul>
<li>Trading volume stands at 3,286,505, with BIDU's price down by -0.11%, positioned at $96.1.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>Professional Analyst Ratings for Baidu</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $176.0.
<ul>
<li>Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Baidu with a target price of $176. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Baidu options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

BIDU

Looking At Baidu's Recent Unusual Options Activity

Ontrak shares are trading lower after the company reported worse-than-expected Q4 financial results.

TCRX

TScan Therapeutics shares are trading lower after the company announced that it commenced a $125 million proposed public offering. The company provided an update on its solid tumor and heme malignancies clinical programs.

United Airlines Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) shares left the runway in Tuesday&#8217;s after-hours session on the heels of the company&#8217;s first-quarter financial results. Here&#8217;s a look at the <a href="https://www.benzinga.com/pressreleases/24/04/n38279693/united-airlines-announces-first-quarter-2024-financial-results-exceeds-revenue-and-eps-expectation">key metrics from the quarter</a>.
Q1 Earnings: United Airlines reported first-quarter revenue of $12.539 billion, which beat the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $12.4 billion, according to&nbsp;<a href="https://benzinga.grsm.io/gxjhpowx7zks" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company reported an adjusted quarterly loss 15 cents per share, which beat analyst estimates for a loss of 57 cents per share.
United said capacity was up 9.1% on a year-over-year basis. TRASM (total revenue per available seat mile) was up 0.6%, while CASM (cost per available seat mile) was down 0.6%.
United said it converted a portion of Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) Max 10 orders to Boeing Max 9 orders from 2025 to 2027. The company also agreed to letters of intent with two lessors to lease 35 new Airbus A321neos, expected in 2026 and 2027. 
United ended the quarter with $16.9 billion in total liquidity and $27.2 billion in total debt and finance lease obligations.
&#8220;We&#8217;ve adjusted our fleet plan to better reflect the reality of what the manufacturers are able to deliver. And, we&#8217;ll use those planes to capitalize on an opportunity that only United has: profitably grow our mid-continent hubs and expand our highly profitable international network from our best in the industry coastal hubs,&#8221; said&nbsp;Scott Kirby, CEO of United Airlines.
Outlook: United Airlines reiterated expectations for full-year 2024 adjusted earnings of $9 to $11 per share versus estimates of $9.67 per share. 
The company also said it now anticipates 61 narrowbody aircraft and 5 widebody aircraft to be delivered in 2024, given the 737 Max grounding and production capacity constraints.
Management will hold a conference call to discuss these results Thursday morning at 10:30 a.m. ET.
See Also: <a href="https://www.benzinga.com/markets/equities/24/04/38257664/delta-flight-returns-to-atlanta-after-takeoff-boeing-757-yawing-aggressively">Delta Flight Returns To Atlanta After Takeoff: Boeing 757 &#8216;Yawing Aggressively&#8217;</a>
UAL Price Action: <a href="https://www.benzinga.com/quote/UAL">United Airlines shares</a> were up 4.75% after hours at $43.47 at the time of publication Tuesday, according to <a href="https://benzinga.grsm.io/gxjhpowx7zks" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Courtesy of United Airlines.

Travel

After-Hours Center

United Airlines Stock Takes Off On Q1 Earnings Beat: The Details

Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) has outperformed the market over the past 20 years by 19.93% on an annualized basis producing an average annual return of 27.62%. Currently, Booking Holdings has a market capitalization of $118.50 billion. 
Buying $1000 In BKNG: If an investor had bought $1000 of BKNG stock 20 years ago, it would be worth $130,367.29 today based on a price of $3467.77 for BKNG at the time of writing.
<h3>Booking Holdings's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713299428_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BKNG

Here's How Much You Would Have Made Owning Booking Holdings Stock In The Last 20 Years

Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) has outperformed the market over the past 15 years by 5.33% on an annualized basis producing an average annual return of 17.96%. Currently, Equinix has a market capitalization of $70.43 billion. 
Buying $100 In EQIX: If an investor had bought $100 of EQIX stock 15 years ago, it would be worth $1,188.37 today based on a price of $742.14 for EQIX at the time of writing.
<h3>Equinix's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713299424_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EQIX

Here's How Much $100 Invested In Equinix 15 Years Ago Would Be Worth Today

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed up 66.67% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/HERTF">Heritage Cannabis Holding</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HERTF#OTC">HERTF</a>) shares closed up 28.57% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/NDVAF">Indiva</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NDVAF#OTC">NDVAF</a>) shares closed up 24.32% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 15.57% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 13.64% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 12.78% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 8.21% at $0.19</li>
<li><a href="https://www.benzinga.com/quote/GENE">Genetic Technologies</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENE#NASDAQ">GENE</a>) shares closed up 6.42% at $3.17</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 6.41% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 6.00% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/RIV">Rivernorth Opps Fund</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIV#NYSE">RIV</a>) shares closed up 5.75% at $11.26</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 5.36% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 4.35% at $1.65</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 4.23% at $0.27</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 3.31% at $4.99</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/INLB">Item 9 Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/INLB#OTC">INLB</a>) shares closed down 33.33% at $0.0002</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Props</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 18.33% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 12.44% at $0.61</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 12.14% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 9.79% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/MGCLF">Argent Biopharma</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGCLF#OTC">MGCLF</a>) shares closed down 7.14% at $0.26</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed down 6.85% at $5.90</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 6.47% at $1.30</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed down 6.04% at $15.39</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 4.93% at $0.91</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 4.57% at $6.48</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed down 4.44% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 4.15% at $6.70</li>
<li><a href="https://www.benzinga.com/quote/PMD">Psychemedics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMD#NASDAQ">PMD</a>) shares closed down 4.15% at $2.56</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 3.75% at $41.12</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 3.27% at $0.05</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

BLOZF

BMMJ

CNBX

CPHRF

CRBP

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

FFNTF

GBHPF

GENE

GNLN

HERTF

INLB

ITHUF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LMLLF

MGCLF

MRMD

NDVAF

RMHB

RSSFF

SOLCF

TGIFF

XXII

YCBD

ZDPY

Cannabis Stock Gainers And Losers From April 16, 2024

Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.21) by 28.57 percent. The company reported quarterly sales of $3.539 which missed the analyst consensus estimate of $4.037 million by 100.00 percent. This is a 100.00 percent decrease over sales of $2.510 million the same period last year.

UPDATE: Ontrak Q4 2023 Adj EPS $(0.27) Misses $(0.21) Estimate, Sales $3.539 Miss $4.037M Estimate

The market has been high on Beyond Air Inc (XAIR)  stock recently. XAIR gets a Bullish score from InvestorsObserver Stock Sentiment Indicator. Beyond Air Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on XAIR!See Full XAIR ReportWhat is Stock Sentiment?When making inv

Do Traders Think Beyond Air Inc (XAIR) Can Keep Climbing Thursday?

Notable earnings after Monday's close

Beyond Air GAAP EPS of -$0.50 beats by $0.04, revenue of $0.4M misses by $0.05M

Beyond Air, Inc. (XAIR) Q3 2024 Earnings Call Transcript

Piper Sandler analyst Jason Bednar reiterated a Buy rating on Beyond Air (XAIR – Research Report) today and set a price target of $7.00. The compan...

Piper Sandler Remains a Buy on Beyond Air (XAIR)

G1 Therapeutics, CareCloud among healthcare movers

Beyond Air Inc (XAIR) reported better than expected earnings this afternoon for Q3 2024. Wall Street earnings per share (EPS) projections for Beyond Air Inc were at a loss of $0.53 per share. The company beat those estimates with an EPS loss of $0.50 per share. The loss of $0.50 per share (which represents a -6% EPS surpri

Beyond Air Inc Down 16.93% To $1.79 After Earnings Beat

Beyond Air Inc (XAIR) has released an update. On February 14, 2024, Jeff Myers, M.D., Ph.D, transitioned from his role as the Chief Medical Officer...

Beyond Air's Former CMO Becomes Paid Consultant

The latest update is out from Beyond Air Inc (XAIR). Beyond Air, Inc. successfully held its 2024 Annual Meeting, where stockholders approved a sign...

Beyond Air's Annual Meeting: Board Elections and Incentive Plan Expansion

Beyond Air rises after pricing its $16M direct offering

ADWPF

ANET

ARKR

ASPN

BDRX

BLKB

CCLD

CDNS

CETX

CSLLY

DOMA

ELVA

GTHX

-

-

-

-

-

-

-

25% Off Benzinga's Most Powerful Trading Tools

-

-

-

-

-

-

-

Beyond Air Stock (NASDAQ:XAIR), Trade Ideas